Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health Dementia

Mindfulness may be a window into brain health in early Alzheimer’s risk

by Eric W. Dolan
May 23, 2025
in Dementia, Mindfulness
[Adobe Stock]

[Adobe Stock]

Share on TwitterShare on Facebook

A new study published in the journal Mindfulness has found that older adults with early signs of cognitive impairment show reduced levels of dispositional mindfulness, and that this decline may be linked to changes in brain connectivity. Specifically, the researchers identified weaker functional connections in the ventromedial prefrontal cortex—a brain region involved in emotional regulation—as a predictor of lower mindfulness in individuals with mild cognitive impairment.

The study was conducted to better understand how mindfulness traits change in the early stages of cognitive decline, before a diagnosis of dementia is made. The researchers focused on two groups: individuals with subjective cognitive decline, who report memory issues despite normal test performance, and those with mild cognitive impairment, who show measurable deficits but still maintain independence in daily life. Both groups are at increased risk of developing Alzheimer’s disease, and identifying early behavioral or neurological changes could aid in prevention and intervention efforts.

Mindfulness, often cultivated through practices like meditation, is also considered a stable personality trait. People naturally vary in their ability to remain present and aware of their thoughts and feelings. This capacity, known as dispositional mindfulness, has been linked to improved attention, emotional regulation, and brain health in prior studies involving healthy individuals. However, little research has explored how this trait may change in people experiencing early cognitive decline, or how it relates to brain function and structure.

To investigate these questions, the research team recruited 79 older adults—48 with subjective cognitive decline and 31 with mild cognitive impairment—from the Czech Brain Aging Study. All participants underwent cognitive assessments, brain imaging, and a behavioral test of mindfulness called the Breath Counting Task. In this task, participants were instructed to count their breaths in cycles of nine over an 18-minute period, with accuracy measured through physiological data. Unlike questionnaires, this task offers a direct behavioral measure of mindfulness.

The researchers also conducted advanced brain imaging, including structural and functional magnetic resonance imaging. They focused on specific brain regions previously linked to mindfulness and cognitive decline: the hippocampus (important for memory), the posterior cingulate cortex (involved in mind-wandering), the rostral anterior cingulate cortex (linked to self-awareness), and the ventromedial prefrontal cortex (associated with emotional appraisal and decision-making). Connectivity between brain regions was examined using resting-state functional imaging, while brain structure was assessed through volumetric and diffusion-weighted scans.

The results showed that participants with mild cognitive impairment had significantly lower mindfulness scores on the Breath Counting Task than those with subjective cognitive decline. This group difference remained statistically significant even after adjusting for age and other factors. Interestingly, differences in cognitive performance on traditional memory and attention tests did not predict mindfulness scores in either group. This suggests that the ability to maintain mindful attention may reflect distinct mental processes not captured by standard cognitive tests.

One of the most important findings was that greater functional connectivity in the ventromedial prefrontal cortex predicted higher mindfulness scores in individuals with mild cognitive impairment. This relationship was not found in those with subjective cognitive decline, indicating a possible compensatory mechanism in more impaired individuals. In other words, people in the early stages of measurable cognitive loss may need to rely more heavily on this brain region to sustain mindful awareness.

No significant associations were found between mindfulness scores and brain structure in any of the examined regions, including the hippocampus and posterior cingulate cortex. This was somewhat surprising given prior research linking mindfulness training to changes in gray matter volume in these areas. The authors suggest that structural brain differences may be less sensitive to subtle variations in dispositional mindfulness, or that longer-term meditation practice may be required to influence brain anatomy.

The study’s findings underscore the potential of mindfulness as both a behavioral marker and a modifiable factor in cognitive aging. Because mindfulness has been linked to reduced stress and improved emotional coping, higher levels of dispositional mindfulness may help buffer against the effects of cognitive decline. Moreover, the fact that individuals with mild impairment showed lower mindfulness but still maintained the ability to engage in the breath-counting task suggests that mindfulness interventions could be feasible and beneficial for this population.

One of the strengths of the study is its use of a behavioral measure of mindfulness rather than relying solely on self-reported questionnaires, which can be biased or less reliable in older adults. The Breath Counting Task provides a quantifiable index of attentional stability, which may be especially relevant in assessing early cognitive changes. Additionally, the integration of multiple brain imaging methods allowed the researchers to examine both functional and structural correlates of mindfulness.

However, the study was cross-sectional, meaning it cannot determine whether lower mindfulness causes cognitive decline, results from it, or simply reflects parallel changes. Longitudinal studies are needed to understand how mindfulness and brain function co-evolve over time in aging individuals. Another limitation was the lack of biomarker data to confirm whether participants with mild impairment were on a trajectory toward Alzheimer’s disease. Including such data in future research could help clarify whether the observed changes are specific to this condition.

The study, “Present Mind in the Ageing Brain: Neural Associations of Dispositional Mindfulness in Cognitive Decline,” was authored by Rastislav Šumec, Pavel Filip, Martin Vyhnálek, Stanislav Katina, Dusana Dorjee, Jakub Hort, and Kateřina Sheardová.

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

Scientists find 16 new Alzheimer’s-linked genes using multi-ancestry genome data
Alzheimer's Disease

Scientists find 16 new Alzheimer’s-linked genes using multi-ancestry genome data

May 23, 2025

A groundbreaking genome-wide analysis has revealed new genetic regions associated with Alzheimer’s disease—many missed in past studies focused on European populations. The findings point to underexplored biological pathways and highlight the value of studying diverse ancestry groups.

Read moreDetails
New eye test may detect Alzheimer’s disease years before symptoms emerge, study suggests
Alzheimer's Disease

New eye test may detect Alzheimer’s disease years before symptoms emerge, study suggests

May 18, 2025

A low-cost, noninvasive eye scan could help detect Alzheimer’s disease earlier than current methods. The technique may expand access to early diagnosis, especially in underserved communities, and provide a valuable tool for intervention before irreversible brain damage occurs.

Read moreDetails
Could this natural protein be the key to reversing age-related memory loss?
Dementia

Could this natural protein be the key to reversing age-related memory loss?

May 17, 2025

Scientists have discovered that increasing levels of a protein called Hevin in the brain reverses memory loss in aging and Alzheimer’s model mice. The findings suggest a new way to improve cognition without targeting amyloid plaques.

Read moreDetails
Loss of empathy in frontotemporal dementia traced to weakened brain signals
Dementia

Loss of empathy in frontotemporal dementia traced to weakened brain signals

May 16, 2025

A brain scan study comparing dementia patients to healthy individuals reveals how frontotemporal dementia impairs emotional empathy. The findings could help scientists understand the disease’s early progression and eventually guide development of targeted interventions.

Read moreDetails
Caffeine and Alzheimer’s disease: Moderate intake may slow cognitive decline
Alzheimer's Disease

Caffeine and Alzheimer’s disease: Moderate intake may slow cognitive decline

May 15, 2025

A recent review published in Cureus explores the relationship between caffeine and Alzheimer’s disease. The findings suggest that higher caffeine intake may reduce the risk of cognitive decline, especially in people with early symptoms of memory impairment.

Read moreDetails
The brain is shown with a wave of sound
Alzheimer's Disease

Abnormal brain rhythms may offer new insight into Alzheimer’s disease and its link to epilepsy

May 12, 2025

A study using magnetoencephalography found that Alzheimer’s patients show increased high-frequency brain oscillations, even without epileptic activity. These waveforms may offer a new biomarker for hyperexcitability and help identify those who could benefit from targeted seizure treatments.

Read moreDetails
Shifting genetic tides: How early language skills forecast ADHD and literacy outcomes
Alzheimer's Disease

Genetic mutations predict Alzheimer’s onset like a ticking clock, study finds

May 11, 2025

New research reveals that mutations in three genes linked to familial Alzheimer’s can predict when symptoms begin, acting like molecular clocks. The study may help improve diagnosis and inform targeted therapies for early-onset forms of the disease.

Read moreDetails
Early accumulation of tau in the brain associated with a rapid decline of episodic memory in Alzheimer’s disease
Alzheimer's Disease

Experimental vaccine targeting tau protein shows promise for Alzheimer’s disease

May 6, 2025

A novel vaccine targeting a toxic form of tau protein reduced brain atrophy and improved memory in mice and monkeys. The study offers a potentially safer, longer-lasting, and more cost-effective approach than current antibody-based Alzheimer’s treatments.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Mindfulness may be a window into brain health in early Alzheimer’s risk

Judgments of breast attractiveness show surprising consistency across gender, race, and orientation

Neuroscientists challenge “dopamine detox” trend with evidence from avoidance learning

Non-right-handedness is more common across multiple mental health conditions

Withdrawal symptoms are common after stopping antidepressants

Anxious attachment linked to depression spillover in romantic relationships, study finds

Scientists find 16 new Alzheimer’s-linked genes using multi-ancestry genome data

Groundbreaking AI model uncovers hidden patterns of political bias in online news

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy